GERMANTOWN, MD AND HOUSTON, TX / ACCESS Newswire / December 9, 2025 / uBriGene Biosciences, a global CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development and manufacturing, ...
RNA-based medicines are transforming the way we treat disease—offering targeted, precision therapies for conditions ranging ...
A collaborative study by scientists at the University of California, Riverside, and University of Southern California reports on how a process known as alternative splicing, often described as ...
Researchers may have found a way to create synthetic RNA that is more “pure” and cost-effective than previous approaches, expanding opportunities for medicine and therapeutics. According to research ...
From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...
When a gene is expressed, its DNA sequence is transcribed into a molecule known as RNA. Then the cell processes and edits ...
RNA is a central biological macromolecule, now widely harnessed in medicine and nanotechnology. Like proteins, RNA function ...
A study captured the first near frame-by-frame view of a self-splicing ribozyme assembling into its active form. Using ...
A new Northwestern University-led study is unfolding the mystery of how RNA molecules fold themselves to fit inside cells and perform specific functions. The findings could potentially break down a ...